Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Simple Search

Search Type: Criteria:

You could also try: inside layer (24), coating (68), liner (5)

Vinorelbine (intravenous)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Intravenous) Regimen NSCLC - Vinorelbine (Intravenous) Indication Second line therapy of stage III
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineintravenousver12.pdf

Ibrutinib (WM) (420mg)

Description: Chemotherapy Protocol Waldenström's Macroglobulinaemia (WM) Regimen Ibrutinib • WM – Ibrutinib (420mg) Indication • The treatment of adult patients with Waldenström's Macroglobulinaemia (WM) who
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-WM-420mg.pdf

Imatinib v1

Description: Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Imatinib Regimen GIST-Imatinib Indication Imatinib is recommended as a possible adjuvant treatment
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Imatinib-v1.pdf

Cyclophosphamide Topotecan v1.1

Description: Chemotherapy Protocol SARCOMA CYCLOPHOSPHAMIDE-TOPOTECAN Regimen Sarcoma – Cyclophosphamide-Topotecan Indication Advanced Ewings sarcoma or rhabdomyosarcoma WHO performance status 0,1, 2
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Cyclophosphamide-Topotecan-v1.1.pdf

Daratumumab

Description: Chemotherapy Protocol Myeloma Daratumumab Regimen • Myeloma – Daratumumab monotherapy Indication • Daratumumab monotherapy is recommended as an option for treating relapsed and refractory
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Daratumumab.pdf

Dabrafenib Ver 1

Description: Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line treatment of
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Recovering well after an endometrial resection or ablation - patient information

Description: This factsheet explains what to expect after having an endometrial resection or ablation, and how you can help your body to
Url: /Media/UHS-website-2019/Patientinformation/Womenshealth/Recovering-well-after-an-endometrial-resection-or-ablation-3054-PIL.pdf

CH001 SOP protocol verification

Description: Standard Operating Procedure Production of Chemotherapy Protocols (SOP:CH001) 1. Objective 1.1 The purpose of this standard operating procedure (SOP
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Validation/CH001SOP-protocol-verification.pdf

Endoscopic submucosal dissection (ESD) - patient information

Description: Patient information factsheet Endoscopic submucosal dissection (ESD) This factsheet aims to help you understand what is involved in
Url: /Media/UHS-website-2019/Patientinformation/Endoscopy/Endoscopic-submucosal-dissection-ESD-2038-PIL.pdf

Septic arthritis - patient information

Description: Your child has recently been diagnosed with septic arthritis and you have been given this factsheet to explain the condition and
Url: /Media/UHS-website-2019/Patientinformation/Childhealth/Septicarthritis-1213-PIL.pdf

431 to 440 of 748

Previous … 42 43 44 45 46 … Next